Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Glucagon has known positive chronotropic and inotropic effects on the heart, meaning it can increase both heart rate and the force of cardiac contractions
Phase 2 trial data (published in New England Journal of Medicine, 2023 ): 24.2% average weight loss at 48 weeks with 12 mg dose 22.8% with 8 mg dose Placebo group lost 2.1% Most recent Phase 3 trial data (TRIUMPH-4, December 2025): 28.7% average weight loss at 68 weeks with 12 mg dose 26.4% with 9 mg dose 58.6% of participants on 12 mg achieved at least 25% weight loss 39.4% achieved at least 30% weight loss For context: These are the highest weight loss numbers reported in any clinical trial for a pharmacological obesity treatment
Novel insights on synergistic strategies Physical exercise can protect against several diseases, especially metabolism-associated disorders, and contribute to health maintenance
DOI: 10.1016/j.eclinm.2025.103363, Further Reading All Glucagon-like Peptide-1 Content Oral GLP-1 Pills for Weight Loss: How Orforglipron Works GLP-1 and Diet: Evidence-Based Strategies for Better Weight Loss Is Berberine Really Natures Ozempic
Accessed May 31, 2020
US$ 23.46
US$ 28.80
US$ 23.21
US$ 24.68
US$ 21.99
